Examine Case Study: An African American Child Suffering From Depression. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.
Decision Point On
Begin Wellbutrin 75 mg orally BID
RESULTS OF DECISION POINT ONE
- Client returns to clinic in four weeks
- Child is unable to fall asleep at night
Decision Point Two
RESULTS OF DECISION POINT TWO
- Client returns to clinic in four weeks
- Child is tolerating Lexapro, and is sleeping at night. There is a 40% reduction in symptom
Decision Point Three
Guidance to Student
At this point, there is no indicating that the PMHNP should change back to Wellbutrin as the child is tolerating the current medication without mention of side effects. Also, the child is experiencing a reduction in symptoms. The PMHNP could also increase the dose to 15 mg orally daily, but the child has only been taking the drug for 4 weeks at this point. It may be more prudent to give the current therapy an additional 4 weeks before making any decisions to change current dose.